Vision Expo East, March 17-19: Avulux to showcase world’s only clinically proven lens that blocks harmful light linked to migraine attacks

NEW YORK – Join Avulux at Vision Expo East in New York (Booth PAN2433) from March 17-19, 2023, to learn about the world’s only clinically proven lens that blocks the harmful light wavelengths linked to migraine attacks.

More than 80 percent of people with migraine are affected by light sensitivity which either triggers or worsens their attacks. The Avulux Migraine & Light Sensitivity Lens is patented new technology, blocking up to 97 percent of harmful blue, amber and red light while letting in over 70 percent of soothing green light. 

The Avulux Migraine & Light Sensitivity Lens is now available through eye care providers and optical retailers in the U.S., Canada, Australia, New Zealand and the U.K.

Find us at Vision Expo East at Booth PAN2433.

Avulux Co-Founder and President Dr. Charles Posternack will be available for interviews during the show.

To learn more about the science behind the Avulux technology, visit www.avulux.com.